ROCKVILLE, Md.--(BUSINESS WIRE)--Dec. 3, 2012--
Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of
the company’s senior management team will provide a corporate overview
presentation at the 31st Annual J.P. Morgan Healthcare
Conference in San Francisco on Tuesday, January 8, 2013 at 10:00AM
Pacific. The presentation may include a discussion of recent
business developments, preliminary 2012 financial results and financial
guidance for full year 2013.
A webcast of this presentation will be available both live and by
replay, accessible from the Emergent website www.emergentbiosolutions.com
under “Investors”.
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty pharmaceutical company seeking to
protect and enhance life by offering specialized products to healthcare
providers and governments to address medical needs and emerging health
threats. Additional information about us may be found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.
Source: Emergent BioSolutions Inc.
Emergent BioSolutions Inc.
Investors Contact:
Robert G.
Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media
Contact:
Tracey Schmitt
Vice President, Corporate
Communications
301-795-1800
SchmittT@ebsi.com
